相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum Glial Fibrillary Acidic Protein: A Neuromyelitis Optica Spectrum Disorder Biomarker
Orhan Aktas et al.
ANNALS OF NEUROLOGY (2021)
Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
Elia Sechi et al.
JAMA NEUROLOGY (2021)
Comparison of the Response to Rituximab between Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibody Diseases
Pierre Durozard et al.
ANNALS OF NEUROLOGY (2020)
MRI differences between MOG antibody disease and AQP4 NMOSD
Sara Salama et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
International multicenter examination of MOG antibody assays
Markus Reindl et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial
Anthony Traboulsee et al.
LANCET NEUROLOGY (2020)
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease
Hyunjin Kim et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Treatment of MOG-IgG-associated disorder with rituximab: An international study of 121 patients
Daniel H. Whittam et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Evaluation of treatment response in adults with relapsing MOG-Ab-associated disease
Alvaro Cobo-Calvo et al.
JOURNAL OF NEUROINFLAMMATION (2019)
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
Bruce A. C. Cree et al.
LANCET (2019)
Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases
Sara Mariotto et al.
NEUROLOGY (2019)
Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder
Takashi Yamamura et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
Kerri Prain et al.
FRONTIERS IN NEUROLOGY (2019)
Classifying the antibody-negative NMO syndromes Clinical, imaging and metabolomic modeling
Tianrong Yeo et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders
Maureen A. Mealy et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Overlapping Autoimmune Syndromes in Patients With Glial Fibrillary Acidic Protein Antibodies
Xinguang Yang et al.
FRONTIERS IN NEUROLOGY (2018)
MOG antibody disease: A review of MOG antibody seropositive neuromyelitis optica spectrum disorder
Ram Narayan et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow et al.
FRONTIERS IN NEUROLOGY (2018)
Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Martin S. Weber et al.
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2018)
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
Maciej Jurynczyk et al.
JOURNAL OF NEUROLOGY (2016)
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Bruce A. C. Cree et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations
Bruce A. C. Cree et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Finding NMO: The Evolving Diagnostic Criteria of Neuromyelitis Optica
Jeffrey L. Bennett
JOURNAL OF NEURO-OPHTHALMOLOGY (2016)
Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis optica
Patrick Waters et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease
Romana Hoeftberger et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
B lymphocytes in neuromyelitis optica
Jeffrey L. Bennett et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Seroprevalence of Aquaporin-4-IgG in a Northern California Population Representative Cohort of Multiple Sclerosis
Sean J. Pittock et al.
JAMA NEUROLOGY (2014)
AQP4 autoantibody assay performance in clinical laboratory service
J. P. Fryer et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2014)
Aquaporin-4 antibody-negative neuromyelitis optica Distinct assay sensitivity-dependent entity
Romain Marignier et al.
NEUROLOGY (2013)
Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients
Sven Jarius et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype
Joanna Kitley et al.
NEUROLOGY (2012)
Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
Simone Mader et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Longitudinal extensive transverse myelitis-it's not all neuromyelitis optica
Corinna Trebst et al.
NATURE REVIEWS NEUROLOGY (2011)
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury
Romain Marignier et al.
BRAIN (2010)
Frequency and prognostic impact of antibodies to aquaporin-4 in patients with optic neuritis
Sven Jarius et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2010)
AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance
Sven Jarius et al.
NATURE REVIEWS NEUROLOGY (2010)
NMO-IgG predicts the outcome of recurrent optic neuritis
M. Matiello et al.
NEUROLOGY (2008)
Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis Optica
Toshiyuki Takahashi et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Revised diagnostic criteria for neuromyelitis optica
D. M. Wingerchuk et al.
NEUROLOGY (2006)
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis
BG Weinshenker et al.
ANNALS OF NEUROLOGY (2006)
分享论文
